Brain natriuretic peptide as a marker of cardiac toxicity in patients with multiple sclerosis treated with mitoxantrone.
Bertora
Pierluigi
P
Torzillo
Daniela
D
Baldi
Gabriella
G
Vago
Tarcisio
T
Mariani
Claudio
C
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D009202:Cardiomyopathies / Q000097:blood* / Q000139:chemically induced / Q000175:diagnosis*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects*; D008991:Monitoring, Physiologic; D009103:Multiple Sclerosis / Q000188:drug therapy*; D020097:Natriuretic Peptide, Brain / Q000032:analysis / Q000097:blood*; D011237:Predictive Value of Tests
D000970:Antineoplastic Agents; D015415:Biomarkers; D020097:Natriuretic Peptide, Brain; D008942:Mitoxantrone